ArticleFrontiers in medicine2026
The digital gatekeeper: a practical operational framework for differentiating pseudo-severe from severe asthma.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Distinguishing between modifiable pseudo-severe (difficult-to-treat) and severe asthma endotypes represents a high-cost clinical challenge in contemporary respiratory medicine. Traditional assessments rely heavily on subjective medication adherence tracking, which is frequently compromised by recall errors and social desirability biases. This visibility gap often results in premature treatment escalation and unwarranted fast-tracking to high-cost advanced biological therapies, creating a substantial financial burden on healthcare infrastructure. Methods: To resolve these tracking limitations, this study operationalizes and validates a data-driven digital gatekeeper pathway, the Saudi Asthma Referral Pathway (SARP), utilizing the centralized national Wasfaty electronic e-prescribing infrastructure across Saudi Arabia. The framework implements a multi-tiered digital gatekeeper triage engine. Over a 90-day evaluation window, the system programmatically extracts e-prescribing records to calculate a strict terminal Medication Possession Ratio (MPR ≥ 80%), while concurrently tracking daily therapeutic continuity via a custom Proportion of Days Covered (PDC) background algorithm. Patients failing the quantitative threshold or presenting critical device handling errors during a standardized pharmacist physical audit are programmatically diverted into a 3-month Adherence Optimization Loop (AOL). Results: The complete operational logic, algorithmic processing engine, and systemic triage gates were successfully established and validated. To verify structural model stability and ensure covariate independence within the triage engine, multi-collinearity linear inversions were executed. The diagnostics yielded highly stable Variance Inflation Factors (VIF) uniformly below the strict boundary threshold (VIF < 2.5), mathematically proving that behavioral adherence metrics, mechanical device technique, and unmanaged comorbidities function as independent predictors. Longitudinal clinical resolution was successfully mapped via a semi-parametric Cox Proportional Hazards Regression model to isolate behavioral impacts independent of the baseline time-to-control shape. Macroeconomic resource stewardship was fully resolved through a finalized health economic cost-avoidance optimization equation, providing a functional mathematical engine to calculate net system budget savings. Conclusion: This framework successfully transitions severe asthma triage away from subjective clinical impressions toward objective passive digital phenotyping. By delivering completed technical architectures, statistical diagnostics, and health economics modeling parameters within the special Research Topic track, this study provides an actionable, highly scalable blueprint for national population-scale medication stewardship and precision respiratory resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.